Evidence map›Paper›PMID 37342493›Full record

ReviewFrontiers in medicine2023

Oxalate as a potent promoter of kidney stone formation.

Tao Chen, Biao Qian, Junrong Zou, Peiyue Luo, Jun Zou, Wei Li, Qi Chen, Liying Zheng

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tao ChenThe First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Biao QianDepartment of Urology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
Junrong ZouDepartment of Urology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
Peiyue LuoThe First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Jun ZouThe First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Wei LiThe First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Qi ChenThe First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Liying ZhengDepartment of Graduate, The First Affiliated Hospital of Ganna Medical University, Ganzhou, Jiangxi, China.
First Affiliated Hospital of Gannan Medical University · CNGanzhou People's Hospital · CNGannan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney stones are among the most prevalent urological diseases, with a high incidence and recurrence rate. Treating kidney stones has been greatly improved by the development of various minimally invasive techniques. Currently, stone treatment is relatively mature. However, most current treatment methods are limited to stones and cannot effectively reduce their incidence and recurrence. Therefore, preventing disease occurrence, development, and recurrence after treatment, has become an urgent issue. The etiology and pathogenesis of stone formation are key factors in resolving this issue. More than 80% of kidney stones are calcium oxalate stones. Several studies have studied the formation mechanism of stones from the metabolism of urinary calcium, but there are few studies on oxalate, which plays an equally important role in stone formation. Oxalate and calcium play equally important roles in calcium oxalate stones, whereas the metabolism and excretion disorders of oxalate play a crucial role in their occurrence. Therefore, starting from the relationship between renal calculi and oxalate metabolism, this work reviews the occurrence of renal calculi, oxalate absorption, metabolism, and excretion mechanisms, focusing on the key role of SLC26A6 in oxalate excretion and the regulatory mechanism of SLC26A6 in oxalate transport. This review provides some new clues for the mechanism of kidney stones from the perspective of oxalate to improve the understanding of the role of oxalate in the formation of kidney stones and to provide suggestions for reducing the incidence and recurrence rate of kidney stones.

Indexed as

gut microbiomehyperoxaluriakidney stoneskindeyoxalateSLC26A6

Identifiers

PMID37342493
PMCPMC10278359
OpenAlexW4379469244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.